WILFORGINE is primarily used in research settings for its immunosuppressive and anti-inflammatory properties. It has been investigated for potential therapeutic applications in autoimmune diseases such as rheumatoid arthritis and lupus due to its ability to modulate T-cell activity and inhibit the production of pro-inflammatory cytokines. Additionally, it shows promise in organ transplantation studies, where it helps prevent graft rejection by suppressing immune response. Some preliminary studies also explore its antitumor effects, particularly in inhibiting the growth of certain cancer cell lines. However, its use remains largely experimental, limited by toxicity and narrow therapeutic window.